148 related articles for article (PubMed ID: 37657359)
1. T helper type 9 cell response and its role in the neurological clinic of patients with Human T-lymphotropic virus 1.
de Sena Rodrigues Júnior R; Antonia Nunes Gomes J; Alberto da Silva Dias G; Fujihara S; Toshimitsu Yoshikawa G; Vilela Lopes Koyama R; Catarina Medeiros Sousa R; Antonio Simões Quaresma J; Thais Fuzii H
Immunobiology; 2023 Nov; 228(6):152740. PubMed ID: 37657359
[TBL] [Abstract][Full Text] [Related]
2. The IL-18, IL-12, and IFN-γ expression in HTLV-1-associated myelopathy/tropical spastic paraparesis (HAM/TSP) patients, HTLV-1 carriers, and healthy subjects.
Bidkhori HR; Hedayati-Moghaddam MR; Mosavat A; Valizadeh N; Tadayon M; Ahmadi Ghezeldasht S; Rafatpanah H; Rezaee SA
J Neurovirol; 2020 Jun; 26(3):338-346. PubMed ID: 32270468
[TBL] [Abstract][Full Text] [Related]
3. HLA-B*35 as a new marker for susceptibility to human T-cell lymphotropic virus type 1 (HTLV-1) Associated Myelopathy/Tropical Spastic Paraparesis (HAM/TSP) in patients living in Argentina.
Benencio P; Fraile Gonzalez SA; Ducasa N; Page K; Berini CA; Biglione MM
Retrovirology; 2020 Sep; 17(1):29. PubMed ID: 32883310
[TBL] [Abstract][Full Text] [Related]
4. High IFN-γ/IL-10 expression ratio and increased frequency of persistent human T-cell lymphotropic virus type 1-infected clones are associated with human T-cell lymphotropic virus type 1-associated myelopathy/tropical spastic paraparesis development.
Espíndola OM; Oliveira LC; Ferreira PM; Leite AC; Lima MA; Andrada-Serpa MJ
Intervirology; 2015; 58(2):106-14. PubMed ID: 25833232
[TBL] [Abstract][Full Text] [Related]
5. Incomplete myelopathy and human T cell lymphotropic virus type-1 (HTLV-1).
Koyama RVL; Yoshikawa GT; Fujihara S; da Silva Dias GA; Virgolino RR; Rodrigues AR; Medeiros R; Simões Quaresma JA; Fuzii HT
J Neurovirol; 2019 Feb; 25(1):1-8. PubMed ID: 30291566
[TBL] [Abstract][Full Text] [Related]
6. Decrease in naïve T cell production due to HTLV-1-associated myelopathy/tropical spastic paraparesis (HAM/TSP) development.
Gomes JAN; da Silva Dias GA; Fujihara S; Yoshikawa GT; Koyama RVL; Sousa RCM; Quaresma JAS; Fuzii HT
Immunobiology; 2021 Jan; 226(1):152050. PubMed ID: 33338979
[TBL] [Abstract][Full Text] [Related]
7. Balance Impairments in Patients with Human T-Cell Lymphotropic Virus Type 1 Infection.
Vasconcelos BHB; Callegari B; Costa KHA; Barroso TGCP; Sousa RCM; Saunier G; Xavier MB; Souza GS
Sci Rep; 2019 Aug; 9(1):11456. PubMed ID: 31391511
[TBL] [Abstract][Full Text] [Related]
8. Role of IL-21 in HTLV-1 infections with emphasis on HTLV-1-associated myelopathy/tropical spastic paraparesis (HAM/TSP).
Rajaei T; Farajifard H; Rafatpanah H; Bustani R; Valizadeh N; Rajaei B; Rezaee SA
Med Microbiol Immunol; 2017 Jun; 206(3):195-201. PubMed ID: 28378248
[TBL] [Abstract][Full Text] [Related]
9. Polymorphisms at GLUT1 gene are not associated with the development of TSP/HAM in Brazilian HTLV-1 infected individuals and the discovery of a new polymorphism at GLUT1 gene.
Costa GC; Azevedo R; Gadelha SR; Kashima SH; Muricy G; Olavarria VN; Covas DT; Takayanagui OM; Galvão-Castro B; Alcantara LC
J Med Virol; 2009 Mar; 81(3):552-7. PubMed ID: 19152396
[TBL] [Abstract][Full Text] [Related]
10. Tropical spastic paraparesis and HTLV-1 associated myelopathy: clinical, epidemiological, virological and therapeutic aspects.
Gessain A; Mahieux R
Rev Neurol (Paris); 2012 Mar; 168(3):257-69. PubMed ID: 22405461
[TBL] [Abstract][Full Text] [Related]
11. Lack of association between single-nucleotide polymorphisms of pro- and anti-inflammatory cytokines and HTLV-1-associated myelopathy / tropical spastic paraparesis development in patients from Rio de Janeiro, Brazil.
Schor D; Porto LC; Roma EH; Quintana MSB; Fabricio-Silva GM; Bonecini-Almeida MG; Araújo AQ; Andrada-Serpa MJ
BMC Infect Dis; 2018 Nov; 18(1):593. PubMed ID: 30466392
[TBL] [Abstract][Full Text] [Related]
12. Infective dermatitis has similar immunological features to human T lymphotropic virus-type 1-associated myelopathy/tropical spastic paraparesis.
Nascimento MC; Primo J; Bittencourt A; Siqueira I; de Fátima Oliveira M; Meyer R; Schriefer A; Santos SB; Carvalho EM
Clin Exp Immunol; 2009 Jun; 156(3):455-62. PubMed ID: 19438598
[TBL] [Abstract][Full Text] [Related]
13. HTLV-1 subgroups associated with the risk of HAM/TSP are related to viral and host gene expression in peripheral blood mononuclear cells, independent of the transactivation functions of the viral factors.
Yasuma K; Matsuzaki T; Yamano Y; Takashima H; Matsuoka M; Saito M
J Neurovirol; 2016 Aug; 22(4):416-30. PubMed ID: 26635027
[TBL] [Abstract][Full Text] [Related]
14. Evaluation of HTLV-1 HBZ and proviral load, together with host IFN λ3, in pathogenesis of HAM/TSP.
Mozhgani SH; Jaberi N; Rezaee SA; Bustani R; Jazayeri SM; Akbarin MM; Milani S; Tarokhian H; Norouzi M
J Med Virol; 2017 Jun; 89(6):1102-1107. PubMed ID: 27787900
[TBL] [Abstract][Full Text] [Related]
15. Infective dermatitis and human T cell lymphotropic virus type 1-associated myelopathy/tropical spastic paraparesis in childhood and adolescence.
Primo JR; Brites C; Oliveira Mde F; Moreno-Carvalho O; Machado M; Bittencourt AL
Clin Infect Dis; 2005 Aug; 41(4):535-41. PubMed ID: 16028164
[TBL] [Abstract][Full Text] [Related]
16. Inhibition of ABL1 tyrosine kinase reduces HTLV-1 proviral loads in peripheral blood mononuclear cells from patients with HTLV-1-associated myelopathy/tropical spastic paraparesis.
Kodama D; Tanaka M; Matsuzaki T; Izumo K; Nakano N; Matsuura E; Saito M; Nagai M; Horiuchi M; Utsunomiya A; Takashima H; Kubota R; Izumo S
PLoS Negl Trop Dis; 2020 Jul; 14(7):e0008361. PubMed ID: 32667912
[TBL] [Abstract][Full Text] [Related]
17. Human T cell lymphotropic virus type 1 (HTLV-1) proviral load of HTLV-associated myelopathy/tropical spastic paraparesis (HAM/TSP) patients according to new diagnostic criteria of HAM/TSP.
Grassi MF; Olavarria VN; Kruschewsky Rde A; Mascarenhas RE; Dourado I; Correia LC; de Castro-Costa CM; Galvão-Castro B
J Med Virol; 2011 Jul; 83(7):1269-74. PubMed ID: 21567429
[TBL] [Abstract][Full Text] [Related]
18. HTLV-1 evades type I interferon antiviral signaling by inducing the suppressor of cytokine signaling 1 (SOCS1).
Olière S; Hernandez E; Lézin A; Arguello M; Douville R; Nguyen TL; Olindo S; Panelatti G; Kazanji M; Wilkinson P; Sékaly RP; Césaire R; Hiscott J
PLoS Pathog; 2010 Nov; 6(11):e1001177. PubMed ID: 21079688
[TBL] [Abstract][Full Text] [Related]
19. Expression of TSLC1 in patients with HAM/TSP.
Takenouchi N; Tanaka M; Sato T; Yao J; Fujisawa JI; Izumo S; Kubota R; Matsuura E
J Neurovirol; 2020 Jun; 26(3):404-414. PubMed ID: 32285300
[TBL] [Abstract][Full Text] [Related]
20. Increased mRNA expression of Th1-cytokine signaling molecules in patients with HTLV-I-associated myelopathy/tropical spastic paraparesis.
Nishiura Y; Nakamura T; Fukushima N; Moriuchi R; Katamine S; Eguchi K
Tohoku J Exp Med; 2004 Dec; 204(4):289-98. PubMed ID: 15572854
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
